Healing & Recovery Stack — Research Stack Protocol (2026)
⚠️ Research Use Only. This post is educational and does not constitute medical advice. All peptides discussed are sold for research purposes only. See our full disclaimer.
Aggressive tissue repair for acute and chronic injuries
Overview
The healing stack combines the most-researched tissue repair peptides for situations where standard recovery time is inadequate — chronic tendinosis, post-surgical recovery, persistent ligamentous insufficiency, or complex injury patterns.
Peptides in This Stack
BPC-157
Healing & Recovery · High
BPC-157 is one of the most researched healing peptides, studied extensively for tendon, ligament, and gut repair in animal models.
TB-500
Healing & Recovery · High
TB-500 is a synthetic peptide derived from Thymosin Beta-4, studied for its systemic healing and anti-inflammatory properties.
GHK-Cu
Healing & Recovery · Moderate
GHK-Cu is a naturally occurring copper-binding tripeptide studied for skin remodeling, wound healing, and hair follicle research.
ARA-290
Healing & Recovery · Moderate
ARA-290 is an 11-amino-acid peptide derived from erythropoietin, studied for neuropathic pain and tissue repair without affecting red blood cell production.
Stack Rationale
BPC-157 drives local angiogenesis and fibroblast recruitment. TB-500 supports systemic cell migration. GHK-Cu remodels connective tissue and accelerates wound closure through gene expression changes. ARA-290 reduces inflammation and supports tissue repair without affecting bone marrow. Each addresses a different layer of the healing cascade.
Research Protocol
Research protocol example: BPC-157 500 mcg/day subq, TB-500 5 mg subq twice weekly for 2 weeks then weekly, GHK-Cu 1-2 mg subq 3x weekly or topical 0.1% formulation, ARA-290 4 mg/day subq during acute phase. Run 4-6 weeks then taper.
The above represents protocols reported in research literature and research community use. These are not recommendations for human dosing or self-administration.
Reported Research Outcomes
Research literature suggests accelerated wound closure, faster return of tensile strength in connective tissue, and reduced scar formation. Most evidence comes from animal models; human translation is anecdotal.
Cautions & Considerations
This is an aggressive multi-peptide protocol that should not be used casually. The inflammation-reduction effects may mask injury signals — researchers should avoid returning to high-load training too soon. ARA-290 has limited vendor availability and quality concerns.
Research Use Only — Compliance Notice
The peptides discussed in this stack are sold for research purposes only. None of this content is medical advice or intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Always consult a qualified medical professional before considering any peptide-related protocols.
